PEMACLAV® 625 MG TABLETS (AMOXICILLIN 500 MG + CLAVULANATE POTASSIUM 125 MG)
PEMACLAV® 625 MG TABLETS (AMOXICILLIN 500 MG + CLAVULANATE POTASSIUM 125 MG)
NAFDAC REG. NUMBER: A4-3832
COMPOSITION: Each tablet contains 500 mg of Amoxicillin as Amoxicillin Trihydrate U.S.P and 125 mg of Clavulanic Acid as Clavulanate Potassium U.S.P
PRODUCT PACKAGING: 14 white, oblong-shaped tablets in foil blister strips, inside a foil pack (2 blisters of 7 tablets)
INDICATIONS:
Pemaclav is indicated in the treatment of following infections caused by susceptible organisms
- Upper respiratory tract infections: sinusitis, tonsillitis, pharyngitis, etc.
- Lower respiratory tract infections: acute bronchitis, pneumonia, pulmonary abscess, etc.
- Urinary tract infections: cystitis, urethritis, pyelonephritis, prostatitis, pelvic inflammatory diseases, gonorrhea, chancroid, etc.
- Skin and soft tissue infections: furuncle, abscess, phlegmona, wound infection, intraperitoneal sepsis.
- Other infections: otitis media, osteomyelitis, sepsis, peritonitis, postoperative infections
Additional Information
BENEFITS
For infections caused by beta-lactamase producing gram-positive and graam-negative amoxicillin sensitive becteria such as:
- H.Pylori gut infections
- Pneumonia
- Urinary tract infections
- Sexually-transmitted diseases
- Skin & tissue infections
- Acute & chronic otitis media
CONSULT YOUR PHYSICIAN BEFORE USING THIS MEDICINE.
KEEP ALL MEDICINES OUT OF REACH OF CHILDREN!
MANUFACTURED BY: REYOUNG PHARMACEUTICAL CO. LTD. FOR PEMASON PHARMACEUTICALS LIMITED